Element Capital Management LLC Glycomimetics Inc Transaction History

Element Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.19 $728,881 - $956,064	-49,821 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.06 - $25.35 $800,125 - $1.26 Million	49,821 New	49,821 $809,000
Q4 2017 Feb 14, 2018	SELL	$10.51 - $17.22 $314,343 - $515,032	-29,909 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$10.14 - $14.85 $542,997 - $795,217	-53,550 Reduced 64.16%	29,909 $418,000
Q2 2017 Aug 14, 2017	BUY	N/A	83,459	83,459 $931,000

25.7M

1.94M

153K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $22.5M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.